Publication number: 20180267020
Abstract: Provided herein are methods of diagnosing and/or treating ACVS, by determining expression levels of several ACVS-related molecules, such as FABP3, ANPR-1, IGFBP-3, F9, SELL, apoB100, ADPN, vWF, THBS1, PRL, PON3, EGFR, VEGF-D, HPX, MBT, F5, F10, SERPIN A5, HCII, and HABP2, for example in a blood sample.
Type:
Application
Filed:
March 19, 2018
Publication date:
September 20, 2018
Applicants:
UVic Industry Partnerships Inc., Vancouver Island Health Authority, British Columbia Center for Disease Control, The Governors of the University of Calgary
Inventors:
Andrew Penn, Christoph Hermann Borchers, Mary Louise Lesperance, Angela Marie Jackson, Maximilian Barnaby Bibok, Viera Saly, Robert Fred Balshaw, Shelagh Brown Coutts